160 related articles for article (PubMed ID: 27484319)
21. Inaugural special issue in research translation.
Tarter R
Am J Drug Alcohol Abuse; 2009; 35(4):205. PubMed ID: 20180670
[No Abstract] [Full Text] [Related]
22. Gender research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: a summary of findings.
Greenfield SF; Rosa C; Putnins SI; Green CA; Brooks AJ; Calsyn DA; Cohen LR; Erickson S; Gordon SM; Haynes L; Killeen T; Miele G; Tross S; Winhusen T
Am J Drug Alcohol Abuse; 2011 Sep; 37(5):301-12. PubMed ID: 21854272
[TBL] [Abstract][Full Text] [Related]
23. The 20th scientific conference of the Society on NeuroImmune Pharmacology.
Fox HS
J Neuroimmune Pharmacol; 2014 Mar; 9(1):1-2. PubMed ID: 24573530
[TBL] [Abstract][Full Text] [Related]
24. Review of HIV and HCV infection among drug users in China.
Bao YP; Liu ZM; Lu L
Curr Opin Psychiatry; 2010 May; 23(3):187-94. PubMed ID: 20308901
[TBL] [Abstract][Full Text] [Related]
25. Report of the Asian Forum of Chronic Kidney Disease Initiative (AFCKDI) 2007. "Current status and perspective of CKD in Asia": diversity and specificity among Asian countries.
Tsukamoto Y; Wang H; Becker G; Chen HC; Han DS; Harris D; Imai E; Jha V; Li PK; Lee EJ; Matsuo S; Tomino Y; Tungsanga K; Yamagata K; Hishida A
Clin Exp Nephrol; 2009 Jun; 13(3):249-56. PubMed ID: 19288169
[TBL] [Abstract][Full Text] [Related]
26. Adaptation and National Dissemination of a Brief, Evidence-Based, HIV Prevention Intervention for High-Risk Men Who Have Sex with Men.
Herbst JH; Raiford JL; Carry MG; Wilkes AL; Ellington RD; Whittier DK
MMWR Suppl; 2016 Feb; 65(1):42-50. PubMed ID: 26916033
[TBL] [Abstract][Full Text] [Related]
27. Estimating the size of key populations at higher risk of HIV infection: a summary of experiences and lessons presented during a technical meeting on size estimation among key populations in Asian countries.
Yu D; Calleja JM; Zhao J; Reddy A; Seguy N;
Western Pac Surveill Response J; 2014; 5(3):43-9. PubMed ID: 25320676
[TBL] [Abstract][Full Text] [Related]
28. The war on drugs: a devastating public-policy disaster.
Wood E; Werb D; Marshall BD; Montaner JS; Kerr T
Lancet; 2009 Mar; 373(9668):989-90. PubMed ID: 19282025
[No Abstract] [Full Text] [Related]
29. Partnerships in drug abuse prevention services research: perspectives from the National Institute on Drug Abuse.
Robertson EB; Sims BE; Reider EE
Adm Policy Ment Health; 2012 Jul; 39(4):327-30. PubMed ID: 22203328
[No Abstract] [Full Text] [Related]
30. U.S. Conference of Mayors Report targets HIV prevention and women.
Makulowich GS
AIDS Patient Care STDS; 1997 Jun; 11(3):200. PubMed ID: 11361806
[No Abstract] [Full Text] [Related]
31. HIV infection among injecting drug users in Asia: an evolving public health crisis.
Wodak A; Crofts N; Fisher R
AIDS Care; 1993; 5(3):313-20. PubMed ID: 8218466
[TBL] [Abstract][Full Text] [Related]
32. HIV Prevention Services in Residential Substance Use Disorder Treatment Facilities in the United States.
Ware OD; Srivastava A; Masa R; Baca-Atlas SN; Chowa G
AIDS Educ Prev; 2023 Apr; 35(2):173-183. PubMed ID: 37129590
[TBL] [Abstract][Full Text] [Related]
33. U.S. prisons fail to adopt proven prevention measures, experts say.
AIDS Policy Law; 1997 Apr; 12(6):1, 9-10. PubMed ID: 11364177
[TBL] [Abstract][Full Text] [Related]
34. Responding to the AIDS epidemic in Asia and the Pacific: report on the Third International Conference on AIDS in Asia and the Pacific, Chiang Mai, Thailand, 17-21 September, 1995.
Ford NJ
AIDS Care; 1996 Feb; 8(1):117-24. PubMed ID: 8664364
[TBL] [Abstract][Full Text] [Related]
35. Planning the new national institute on substance use and addiction disorders.
Nestler EJ; Krystal JH
Biol Psychiatry; 2012 Aug; 72(3):166-7. PubMed ID: 22683089
[No Abstract] [Full Text] [Related]
36. Should the reorganization of addiction-related research across all the National Institutes of Health be structural?--The devil is truly in the details.
Johnson BA; Messing RO; Charness ME; Crabbe JC; Goldman MS; Harris RA; Kranzler HR; Mitchell MC; Nixon SJ; Riley EP; Schuckit MA; Sher KJ; Thomas JD
Alcohol Clin Exp Res; 2011 Apr; 35(4):572-80. PubMed ID: 21443646
[TBL] [Abstract][Full Text] [Related]
37. Women living with drug abuse and HIV disease: drug abuse treatment access and secondary prevention issues.
Weissman G; Melchior L; Huba G; Smereck G; Needle R; McCarthy S; Jones A; Genser S; Cottler L; Booth R
J Psychoactive Drugs; 1995; 27(4):401-11. PubMed ID: 8788695
[TBL] [Abstract][Full Text] [Related]
38. Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network.
Hien DA; Jiang H; Campbell AN; Hu MC; Miele GM; Cohen LR; Brigham GS; Capstick C; Kulaga A; Robinson J; Suarez-Morales L; Nunes EV
Am J Psychiatry; 2010 Jan; 167(1):95-101. PubMed ID: 19917596
[TBL] [Abstract][Full Text] [Related]
39. Confronting the HIV pandemic.
Nathanson N; Auerbach JD
Science; 1999 Jun; 284(5420):1619. PubMed ID: 10383335
[No Abstract] [Full Text] [Related]
40. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
